Search results for "Nephrology"

showing 10 items of 673 documents

HCV-associated cryoglobulinaemia presenting with vasculitis, hepatitis, and glomerulonephritis—a therapeutic dilemma

1996

treated by diet. One year prior to presentation the patient suffered a transitory ischaemic brain attack concomitant with the onset of arterial hypertension, which was subsequently treated with calcium antagonists and beta blockers. Purpura-like skin lesions were noted which were reported to have occurred intermittently over a period of 5 years on both legs and occasionally on the arms. Proteinuria and haematuria were noted during periods with skin lesions.

HepatitisTransplantationPathologymedicine.medical_specialtyProteinuriaVascular diseasebusiness.industryGlomerulonephritismedicine.diseaseCryoglobulinemiaGastroenterologyNephrologyImmunopathologyConcomitantInternal medicinemedicinemedicine.symptombusinessVasculitisNephrology Dialysis Transplantation
researchProduct

Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer

2018

The aim of this multicenter study was to investigate the prognostic role of neutrophil-to-lymphocyte ratio (NLR) and to validate the NLR cutoff of 3 in a large multi-institutional cohort of patients with primary T1 HG/G3 non-muscle-invasive bladder cancer (NMIBC).

High risk; High-grade; NLR; Progression; RecurrenceMaleNeutrophilsmedicine.medical_treatment030232 urology & nephrologySettore MED/24 - Urologia0302 clinical medicineRecurrenceHigh-gradeRecurrence.LymphocytesHigh risk; High-grade; NLR; Progression; Recurrence; Oncology; UrologyAged 80 and overProgressionHigh riskMiddle AgedPrognosis3. Good healthAdministration IntravesicalOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisCohortBCG VaccineDisease ProgressionFemaleNon muscle invasiveAdjuvantAdultmedicine.medical_specialtyUrologyUrologyCystectomyDisease-Free SurvivalNLRResection03 medical and health sciencesmedicineHumansLymphocyte CountNeutrophil to lymphocyte ratioAgedRetrospective StudiesScience & TechnologyBladder cancerbusiness.industryfungimedicine.diseaseConfidence intervalUrinary Bladder NeoplasmsMulticenter studyNeoplasm Recurrence LocalbusinessClinical Genitourinary Cancer
researchProduct

Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer

2017

Background/aim Multiparametric magnetic resonance imaging combined with ultrasound-fusion-targeted biopsy of the prostate intends to increase diagnostic precision, which has to be clarified. Patients and methods We performed multiparametric magnetic resonance imaging followed by ultrasound-fusion-guided perineal biopsy in 99 male patients with elevated prostate-specific-antigen and previous negative standard biopsy-procedures. Results In 33/99 patients (33%) no malignancy could be confirmed by histopathology. Low-grade carcinomas (Gleason-Score 6+7a) were found in 42/66 (64%) and high-grade carcinomas (Gleason-Score ≥7b) in 24/66 (36%) men. A high-grade carcinoma corresponded to PI-RADS 4 o…

Image-Guided BiopsyMaleCancer Researchmedicine.medical_specialty030232 urology & nephrologyMalignancySensitivity and Specificity03 medical and health sciencesProstate cancer0302 clinical medicineProstateBiopsymedicineCarcinomaHumansEndoscopic Ultrasound-Guided Fine Needle AspirationMultiparametric Magnetic Resonance ImagingAgedAged 80 and overmedicine.diagnostic_testbusiness.industryProstateProstatic NeoplasmsReproducibility of ResultsMagnetic resonance imagingGeneral MedicineMiddle AgedProstate-Specific Antigenmedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structureOncology030220 oncology & carcinogenesisHistopathologyRadiologyNeoplasm GradingbusinessAnticancer Research
researchProduct

A Magnetic Resonance Imaging–Based Prediction Model for Prostate Biopsy Risk Stratification

2018

IMPORTANCE: Multiparametric magnetic resonance imaging (MRI) in conjunction with MRI–transrectal ultrasound (TRUS) fusion-guided biopsies have improved the detection of prostate cancer. It is unclear whether MRI itself adds additional value to multivariable prediction models based on clinical parameters. OBJECTIVE: To determine whether an MRI-based prediction model can reduce unnecessary biopsies in patients with suspected prostate cancer. DESIGN, SETTING, AND PARTICIPANTS: Patients underwent MRI, MRI-TRUS fusion-guided biopsy, and 12-core systematic biopsy in 1 session. The development cohort used to derive the prediction model consisted of 400 patients from 1 institution enrolled between …

Image-Guided BiopsyMaleCancer Researchmedicine.medical_specialtyProstate biopsy030232 urology & nephrologyRisk Assessment03 medical and health sciencesProstate cancer0302 clinical medicineProstateBiopsymedicineHumansAgedUltrasonographyOriginal Investigationmedicine.diagnostic_testReceiver operating characteristicbusiness.industryProstateProstatic NeoplasmsMagnetic resonance imagingMiddle AgedPrognosismedicine.diseaseCombined Modality TherapyMagnetic Resonance ImagingTreatment Outcomemedicine.anatomical_structureOncology030220 oncology & carcinogenesisCohortRadiologybusinessImage-Guided BiopsyBiomarkers
researchProduct

Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate can…

2021

Abstract Purpose Men with intermediate risk (IR) prostate cancer (CaP) are often excluded from active surveillance (AS) due to higher rates of adverse pathology (AP). We determined our rate of AP in men who underwent multiparametric MRI (MpMRI) with combined biopsy (CB) consisting of targeted biopsy (TB) and systematic biopsy (SB) prior to radical prostatectomy (RP). Methods A retrospective review was conducted of men with Gleason Grade Group (GG) 2 disease who underwent RP after SB alone or after preoperative MRI with CB. AP was defined as either pathologic stage T3a (AP ≥ T3a) or pathologic stage T3b (AP ≥ T3b) and/or GG upgrading. Rates of AP were determined for both groups and those who…

Image-Guided BiopsyMalePathologymedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyDiseaseGleason gradeLogistic regression03 medical and health sciencesProstate cancer0302 clinical medicineBiopsymedicineHumansRetrospective StudiesProstatectomymedicine.diagnostic_testbusiness.industryProstatectomyProstateProstatic NeoplasmsCancerMiddle Agedmedicine.diseaseMagnetic Resonance ImagingOncology030220 oncology & carcinogenesisbusinessIntermediate riskUrologic Oncology: Seminars and Original Investigations
researchProduct

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer

2018

PURPOSE: We examined the additional value of preoperative prostate multiparametric magnetic resonance imaging and transrectal ultrasound/multiparametric magnetic resonance imaging fusion guided targeted biopsy when performed in combination with clinical nomograms to predict adverse pathology at radical prostatectomy. MATERIALS AND METHODS: We identified all patients who underwent 3 Tesla multiparametric magnetic resonance imaging prior to fusion biopsy and radical prostatectomy. The Partin and the MSKCC (Memorial Sloan Kettering Cancer Center) preradical prostatectomy nomograms were applied to estimate the probability of organ confined disease, extraprostatic extension, seminal vesicle inva…

Image-Guided BiopsyMalePathologymedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyMagnetic Resonance Imaging InterventionalRisk AssessmentArticle03 medical and health sciencesProstate cancer0302 clinical medicinePredictive Value of TestsProstatePreoperative CareImage Processing Computer-AssistedmedicineHumansProspective StudiesUltrasonography InterventionalMultiparametric Magnetic Resonance ImagingAgedRetrospective Studiesbusiness.industryProstatectomyProstateProstatic NeoplasmsMiddle AgedNomogrammedicine.diseaseMagnetic Resonance ImagingPI-RADSProstate-specific antigenNomogramsmedicine.anatomical_structure030220 oncology & carcinogenesisFeasibility StudiesBiopsy Large-Core NeedleNeoplasm GradingbusinessImage-Guided Biopsyhuman activities
researchProduct

Comparison of Elastic and Rigid Registration during Magnetic Resonance Imaging/Ultrasound Fusion-Guided Prostate Biopsy: A Multi-Operator Phantom Stu…

2018

The relative value of rigid or elastic registration during magnetic resonance imaging/ultrasound fusion guided prostate biopsy has been poorly studied. We compared registration errors (the distance between a region of interest and fiducial markers) between rigid and elastic registration during fusion guided prostate biopsy using a prostate phantom model.Four gold fiducial markers visible on magnetic resonance imaging and ultrasound were placed throughout 1 phantom prostate model. The phantom underwent magnetic resonance imaging and the fiducial markers were labeled as regions of interest. An experienced user and a novice user of fusion guided prostate biopsy targeted regions of interest and…

Image-Guided BiopsyMaleProstate biopsyUrology030232 urology & nephrologyImaging phantom03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineFiducial MarkersRegion of interestProstatemedicineHumansUltrasonography Interventionalmedicine.diagnostic_testPhantoms Imagingbusiness.industryUltrasoundProstateProstatic NeoplasmsMagnetic resonance imagingequipment and suppliesmedicine.anatomical_structure030220 oncology & carcinogenesisElasticity Imaging TechniquesFeasibility StudiesbusinessImage-Guided BiopsyFiducial markerNuclear medicineAlgorithmsJournal of Urology
researchProduct

Role of apparent diffusion coefficient values in prostate diseases characterization on diffusion-weighted magnetic resonance imaging.

2019

BACKGROUND: To evaluate if normal and pathological prostate tissue can be distinguished by using apparent diffusion coefficient (ADC) values on magnetic resonance imaging (MRI) and to understand if it is possible to differentiate among pathological prostate tissues using ADC values.METHODS:Our population consisted in 81 patients (mean age 65.4 years) in which 84 suspicious areas were identified. Regions of interest were placed over suspicious areas, detected on MRI, and over areas with normal appearance, and ADC values were recorded. Statistical differences between ADC values of suspicious and normal areas were evaluated. Histopathological diagnosis, obtained from targeted biopsy using MRI-…

Image-Guided BiopsyMaleProstatic DiseasesProstate DiseasesUrologymedicine.medical_treatmentPopulation030232 urology & nephrologyurologic and male genital diseases030218 nuclear medicine & medical imagingDiffusion03 medical and health sciencesProstate cancer0302 clinical medicineProstateImage Processing Computer-AssistedmedicineHumansEffective diffusion coefficienteducationAgedRetrospective StudiesAged 80 and overProstate MRI Diffusion Weighted ImagingAtypical small acinar proliferationeducation.field_of_studymedicine.diagnostic_testbusiness.industryProstatectomyProstateProstatic NeoplasmsMagnetic resonance imagingMiddle Agedmedicine.diseasebody regionsDiffusion Magnetic Resonance Imagingmedicine.anatomical_structureNephrologyNeoplasm GradingbusinessNuclear medicineAlgorithms
researchProduct

Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System

2017

The PI-RADS™ (Prostate Imaging Reporting and Data System), version 2 scoring system, introduced in 2015, is based on expert consensus. In the same time frame ISUP (International Society of Urological Pathology) introduced a new pathological scoring system for prostate cancer. Our goal was to prospectively evaluate the cancer detection rates for each PI-RADS, version 2 category and compare them to ISUP group scores in patients undergoing systematic biopsy and magnetic resonance imaging-transrectal ultrasound fusion guided biopsy.A total of 339 treatment naïve patients prospectively underwent multiparametric magnetic resonance imaging evaluated with PI-RADS, version 2 with subsequent systemat…

Image-Guided BiopsyMalemedicine.medical_specialtyPathologyUrology030232 urology & nephrology030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicinePredictive Value of TestsProstateBiopsymedicineMedical imagingHumansProspective StudiesMultiparametric Magnetic Resonance ImagingAgedUltrasonographymedicine.diagnostic_testbusiness.industryProstatic NeoplasmsMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance ImagingPI-RADSProstate-specific antigenmedicine.anatomical_structureRadiologyNeoplasm GradingbusinessJournal of Urology
researchProduct

Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication Rates

2018

Abstract Background Transrectal prostate biopsy (pbx) is the most frequent outpatient procedure in the urological field. Septic complications are a major health issue. Objective To evaluate complication rates with or without an antimicrobial lubricant. Design, setting, and participants A total of 1000 patients received pbx between 2013 and 2015. Information about complications was collected by a 3-wk questionnaire. Return rate was 73.2% (n = 732). Intervention Randomization for pbx with the instillation of an antimicrobial lubricant (intervention group, n = 385) or the standard lubricant (control group, n = 347) was performed. Outcome measurements and statistical analysis Multivariable anal…

Image-Guided BiopsyMalemedicine.medical_specialtyProstate biopsyFeverUrology030232 urology & nephrologyPatient ReadmissionHematospermialaw.invention03 medical and health sciencesPostoperative Complications0302 clinical medicineRandomized controlled triallawGermanyInternal medicineBiopsymedicineHumansProspective StudiesAgedHematuriaLubricantsmedicine.diagnostic_testbusiness.industryUrinary retentionProstateRectumProstatic NeoplasmsAntibiotic ProphylaxisHemospermiaUrinary RetentionAnti-Bacterial AgentsTransrectal biopsy030220 oncology & carcinogenesisInternational Prostate Symptom Scoremedicine.symptomGastrointestinal HemorrhageComplicationbusinessEuropean Urology Focus
researchProduct